/Investor DB

Pitango — 2023 Investments

10 investments dated 2023 · listed companies and verified rows first · show all

Vertos Medicalvertosmed.comJun 2023 · $26M

Vertos Medical (part of Stryker's Interventional Spine business) develops minimally invasive interventional treatments for chronic pain and reduced mobility, including vertebral augmentation, bone tumor ablation, and basivertebral nerve ablation.

HealthtechMedical DevicesAliso Viejo, US

Eric Wichems(Executive Officer, Director)inRebecca Colbert(Executive Officer)in

BoardMyles Greenberg(Director)Daniel Pelak(Director)John Ryan(Director)

Board seatIttai Harel· per SEC Form D

Co-investorsNorwest Venture PartnersMVM Life Science Partners

Incredoincredo.cominSeries A · May 2023 · $30M

Incredo develops sugar-reduction technology for the food and beverage industry, enabling manufacturers to create better-for-you products with improved taste profiles.

AgTechFoodTech

Aldo Uva(CEO and Chairman)in

Co-investorsFLORA VenturesGefen CapitalRhodiumSienna Venture CapitalTFO GmbHBlueRed Partners+2 more

OpenEyesopeneyes.comin𝕏Series A · Feb 2023 · $18M

OpenEyes provides insurance and telematics technology for commercial fleets, using vehicle and driver data to identify and reduce traffic accident risks.

Enterprise SoftwareInsurTechIoTLogistics & Supply Chain

Yoav Oron(CEO & Co-Founder)inDan Charash(Chairman & Co-Founder)inDr. Omry Sendik(CTO)

Co-investorsInsight PartnersMoreVC

Patient 21patient21.cominSeries C · May 2023 · $76M

Patient21 develops a digital platform to help clinics operate and connect for value-based healthcare, removing administrative burdens from physicians to improve the doctor-patient relationship.

Digital HealthHealthtechMedical DevicesSaaSBerlin, DE

Co-investorsD&FG ElementsTarget GlobalCreandumEight Roads VenturesPICO Venture PartnersPiton Capital LLP

Quant Healthquanthealth.aiin𝕏Series A · Aug 2023 · $15M

QuantHealth provides clinical trial design optimization tools that help pharmaceutical and biotech companies evaluate trial outcomes, competitive positioning, and enrollment feasibility to reduce development risk and accelerate timelines.

AI & Machine LearningBiotechDigital HealthHealthtech

Orr Inbar(Founder)inArnon Horev(Founder)inOrr Inbar Arnon Horev(Founder)

Co-investorsIsrael Innovation AuthorityATOORO FUNDEsplanade VenturesNina CapitalNovaCapitalSanofi Ventures+1 more

Tomorrowtomorrowfoods.com.arin𝕏Jun 2023 · $87M

Tomorrow Foods develops plant-based protein ingredients and turnkey vegetable protein systems for food companies, enabling them to launch plant-based products.

FoodTechNew Materials

Agustín Belloso(CoFounder & CEO)inGuillermo D. Lentini(CoFounder & COO)inCesar A. Belloso(CoFounder)

Co-investorsBlue Horizon CorporationGRIDXACTivate CapitalCanaan PartnersJetBlue VenturesRTX Ventures+1 more

Tomorrowtomorrow.xyzin𝕏Jun 2023 · $87M

Tomorrow offers a self-custodial MPC crypto wallet with built-in succession planning, letting users designate beneficiaries and set a "dead man's switch" that automatically transfers digital assets to heirs after a period of inactivity.

Crypto & Web3Fintech

Co-investorsDraper AssociatesACTivate CapitalCanaan PartnersJetBlue VenturesRTX VenturesSeraphim Space

Volumezvolumez.comSeries A · Apr 2023 · $20M

Volumez offers an agentic AI infrastructure platform that provides a high-performance, governed data foundation for running enterprise AI workloads such as LLM training and fine-tuning, RAG, embedding and index builds, and high-throughput inference.

AI & Machine LearningData & InfrastructureEnterprise SoftwareTel Aviv, IL

Jonathan Amit(Founder)inAmir Faintuchin

Co-investorsKoch Disruptive TechnologiesViola VenturesJ-VenturesSamsung Venture Investment Corporation

Zorromyzorro.coin𝕏Seed · Mar 2023 · $11.5M

Zorro provides a platform that uses data science to help employers manage health benefits more flexibly, allowing employees to select coverage that matches their individual needs rather than rigid group plans.

AI & Machine LearningFintechHealthtechHR TechInsurTech

Guy Ezekiel(Founder)in

Co-investors10DEntrée Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Gina Life

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.